Correlation Between ELYM Old and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both ELYM Old and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ELYM Old and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ELYM Old and Champions Oncology, you can compare the effects of market volatilities on ELYM Old and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ELYM Old with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ELYM Old and Champions Oncology.
Diversification Opportunities for ELYM Old and Champions Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ELYM and Champions is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ELYM Old and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and ELYM Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ELYM Old are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of ELYM Old i.e., ELYM Old and Champions Oncology go up and down completely randomly.
Pair Corralation between ELYM Old and Champions Oncology
If you would invest 862.00 in Champions Oncology on December 29, 2024 and sell it today you would earn a total of 49.00 from holding Champions Oncology or generate 5.68% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ELYM Old vs. Champions Oncology
Performance |
Timeline |
ELYM Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Champions Oncology |
ELYM Old and Champions Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ELYM Old and Champions Oncology
The main advantage of trading using opposite ELYM Old and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ELYM Old position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.The idea behind ELYM Old and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Champions Oncology vs. Agilent Technologies | Champions Oncology vs. Equillium | Champions Oncology vs. 23Andme Holding Co | Champions Oncology vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |